AGRX - Agile Therapeutics Inc.'s (AGRX) CEO Al Altomari on Q2 2021 Results - Earnings Call Transcript

Agile Therapeutics, Inc. (AGRX) Q2 2021 Earnings Conference Call July 26, 2021, 4:30 PM ET Company Participants Matt Riley - Head, Investors Relations Al Altomari - Chairman and CEO Dennis Reilly - Chief Financial Officer Conference Call Participants Oren Livnat - H.C. Wainwright Tim Lugo - William Blair Leland Gershell - Oppenheimer Daniel Busby - RBC Capital Markets Naz Rahman - Maxim Group Presentation Operator Good day, and thank you for standing by. And welcome to the Agile Therapeutics’ 20 -- Q2 2021 Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ remarks, there will be a question-and-answer session. [Operator Instructions] Please be advise that today’s conference is being recorded. [Operator Instructions] I would now like to hand the conference over to your speaker today, Matt Riley, Head of Investors Relations. Please go ahead. Matt Riley Hello, everyone. And

For further details see:

Agile Therapeutics, Inc.'s (AGRX) CEO Al Altomari on Q2 2021 Results - Earnings Call Transcript